Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.adg1659

PubMed Identifier: 37467315

Publication URI: http://europepmc.org/abstract/MED/37467315

Type: Journal Article/Review

Volume: 15

Parent Publication: Science translational medicine

Issue: 705

ISSN: 1946-6234